The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
1996 · Proceedings of the National Academy of Sciences · 47 citations
https://doi.org/10.1073/pnas.93.3.1044
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
72
Citations
2
h-index
2
i10-index
C S Zent is an academic researcher from University of Chicago. The author has contributed to research in topics: Acute Myeloid Leukemia Research & HIV/AIDS drug development and treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 2, co-authored 2 publications.
https://doi.org/10.1073/pnas.93.3.1044
https://doi.org/10.1007/978-3-642-85232-9_24
Click to start Chat